Arkus
Vol. 5 No. 1 (2019): ARKUS

Advances in Psoriasis Biological Agent

Nopriyati (Department of Dermatology and Venereology, Faculty of Medicine, Unibversitas Sriwijaya, Palembang, Indonesia)
Reza Mayasari (Department of Dermatology and Venereology, Faculty of Medicine, Unibversitas Sriwijaya, Palembang, Indonesia)



Article Info

Publish Date
22 Oct 2021

Abstract

Biological agents are proteins that have pharmacological activity, derived from living materials, either from humans, animals, or microorganisms, and can be synthesized in large quantities with the help of genetic engineering techniques (recombinant DNA techniques). Biological agents are divided into three types: monoclonal antibodies in humanized, primatized, fully human, chimeric; cytokines or recombinant human cytokines growth factors; and 3) fusion proteins. The nomenclature for receptor fusion proteins and monoclonal antibodies follows the rules established by the International Nonproprietary Names of the World Health Organization (WHO). The suffix "-cept" is used as a code to identify a drug as a receptor molecule, and "-mab" is used as a code for a monoclonal antibody. The origin of the antibody is indicated by the code "-u-" for fully human origin (e.g., secukinumab). Antibodies derived from humans and mice are humanized, code named "-Zu-" (e.g., ixekizumab or chimeric, "-xi-" (eg, infliximab).

Copyrights © 2019






Journal Info

Abbrev

arkus

Publisher

Subject

Religion Humanities Law, Crime, Criminology & Criminal Justice Medicine & Pharmacology Social Sciences

Description

Arkus publishes original articles, article reviews, and case reports and is designed as a place of dissemination of information and scientific knowledge to develop human wealth. Arkus publishes all manuscripts in multidisciplinary fields (social sciences, sciences, technology, engineering, health, ...